Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Intangibles (2020 - 2025)

Kamada's (KMDA) quarterly Intangibles came in at $126.3 million in Q4 2025, up 22.34% on a YoY basis from $103.2 million in Q4 2024, and up 26.74% quarter-over-quarter from $99.6 million in Q2 2025.

Analysis

Kamada (KMDA) Intangibles (2020 - 2025) Analysis & Trends

Kamada (KMDA) has reported Intangibles for 6 consecutive years, with $126.3 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Intangibles rose 22.34% year-over-year to $126.3 million; the trailing twelve-month figure through Dec 2025 stood at $126.3 million (up 22.34% YoY), and the FY2025 full-year result was $126.3 million, up 22.34% from the prior year.
  • Intangibles rose to $126.3 million in Q4 2025 per KMDA's latest filing, from $99.6 million in the prior quarter.
  • Across five years, Intangibles topped out at $153.7 million in Q4 2021 and bottomed at $3.2 million in Q1 2021.
  • Historically, Intangibles has averaged $113.5 million across 5 years, with a median of $139.5 million in 2023.
  • The sharpest annual moves came in 2021 and 2024: Intangibles soared 9668.79% in 2021, then slipped 26.51% in 2024.
  • Over 5 years, Intangibles stood at $153.7 million in 2021, then slipped by 4.29% to $147.1 million in 2022, then dropped by 4.49% to $140.5 million in 2023, then retreated by 26.51% to $103.2 million in 2024, then grew by 22.34% to $126.3 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods registered $126.3 million, $99.6 million, and $103.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Amgen 211.39 Bn 197.40 Bn 7.24 Bn 20.49 Bn
2 Gilead Sciences 181.14 Bn 177.96 Bn 6.22 Bn 14.03 Bn
3 Vertex Pharmaceuticals 132.24 Bn 124.39 Bn 2.84 Bn 412.80 Mn
4 Regeneron Pharmaceuticals 82.91 Bn 74.91 Bn 3.93 Bn 1.31 Bn
5 Argenx Se 61.55 Bn 56.36 Bn 1.37 Bn 266.00 Mn
6 Moderna 54.39 Bn 49.25 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.43 Bn 31.12 Bn 992.69 Mn -
8 Biogen 31.18 Bn 29.89 Bn 1.96 Bn 13.52 Bn
9 Roivant Sciences 30.11 Bn 30.11 Bn 1.16 Mn -
10 Kamada 472.70 Mn 402.57 Mn 22.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 126.28 Mn
Jun 30, 2025 99.64 Mn
Dec 31, 2024 103.23 Mn
Sep 30, 2024 135.04 Mn
Jun 30, 2024 106.52 Mn
Mar 31, 2024 138.62 Mn
Dec 31, 2023 140.47 Mn
Sep 30, 2023 142.50 Mn
Jun 30, 2023 143.99 Mn
Mar 31, 2023 145.31 Mn
Dec 31, 2022 147.07 Mn
Sep 30, 2022 148.62 Mn
Jun 30, 2022 150.45 Mn
Mar 31, 2022 151.86 Mn
Dec 31, 2021 153.66 Mn
Sep 30, 2021 3.38 Mn
Jun 30, 2021 3.41 Mn
Mar 31, 2021 3.18 Mn
Dec 31, 2020 1.57 Mn